Polyneuropathies encompass a wide range of disorders in which the nerves outside of the brain and spinal cord—peripheral to the central nervous system—have been damaged. Polyneuropathy is also referred to as peripheral neuritis or polyneuritis.
Polyneuropathy is a common disorder with many underlying causes. Some of these causes occur frequently, such as diabetes, and others are extremely rare, such as acrylamide poisoning and certain inherited disorders. The most common worldwide cause of polyneuropathy is leprosy. Leprosy is caused by the bacterium Mycobacterium leprae, which attacks the peripheral nerves. According to statistical data from the World Health Organization, an estimated 1.15 million people suffer from leprosy worldwide.
Leprosy is extremely rare in the United States, where diabetes is the most commonly known cause of polyneuropathy. It has been estimated that more than 17 million people in the United States and Europe suffer from diabetes-related polyneuropathy. Many neuropathies are idiopathic, meaning that no known cause can be found. The most common inherited polyneuropathy in the United States is Charcot-Marie-Tooth disease, which affects approximately 125,000 persons.
Another of the better known polyneuropathies is Guillain-Barré syndrome (GBS, acute idiopathic demyelinating polyneuropathy); it is a complication of such viral illnesses, as cytomegalovirus, Epstein-Barr virus, and human immunodeficiency virus (HIV) or bacterial infection, including Campylobacter jejuni and Lyme disease. The worldwide incidence rate is approximately 1.7 cases per 100,000 people annually. Other well-known causes of polyneuropathies include chronic alcoholism, infection, varicella-zoster virus, botulism, and poliomyelitis. Polyneuropathy may develop as a primary symptom, or it may be due to another disease. For example, polyneuropathy is only one symptom of such diseases as amyloid neuropathy, certain cancers, or inherited neurologic disorders. Such diseases may affect the peripheral nervous system (PNS) and the central nervous system (CNS), as well as other body tissues.
To understand polyneuropathy and its underlying causes, it may be helpful to review the structures and arrangement of the PNS.
Nerve cells and nerves
Nerve cells are the basic building block of the nervous system. In the PNS, nerve cells can be threadlike—their width is microscopic, but their length may be measured in feet. The long, spidery extensions of nerve cells are called axons. When a nerve cell is stimulated—by touch or pain, for example—the message is carried along the axon, and neurotransmitters are released within the cells. Neurotransmitters are chemicals within the nervous system that direct nerve-cell communication.
Certain nerve cell axons, such as those in the PNS, are covered with a substance called myelin. This myelin sheath may be compared to the plastic insulation coating electrical wires—it both protects the cells and prevents interference with the signals being transmitted. Protection is also given by Schwann cells, special cells within the nervous system that wrap around both myelinated and unmyelinated axons.
Nerve cell axons leading to the same areas of the body may be bundled together into nerves. Continuing the comparison to electrical wires, nerves may be compared to an electrical cord—the individual components being coated in their own sheaths and then encased together inside a larger protective sheath.
The nervous system is classified into two parts: the CNS and the PNS. The CNS is the brain and the spinal cord, and the PNS is composed of the nerves that lead to or branch off from the CNS.
Peripheral nervous system
The peripheral nerves handle a diverse array of functions in the body. This diversity is reflected in the major divisions of the PNS—the afferent and the efferent divisions. The afferent division conveys sensory information
from the body to the CNS. When afferent nerve cell endings, called receptors, are stimulated, they release neurotransmitters. These neurotransmitters relay a signal to the brain, which interprets it and reacts by releasing other neurotransmitters.
Some of the neurotransmitters released by the brain are directed at the efferent division of the PNS. The efferent nerves control voluntary movements, such as moving the arms and legs; and involuntary movements, such as making the heart pump blood. The nerves controlling voluntary movements are called motor nerves, and the nerves controlling involuntary actions are referred to as autonomic nerves. The afferent and efferent divisions continually interact with one another.
NERVE DAMAGE. When a patient suffers from a polyneuropathy, nerves of the PNS have been damaged. Nerve damage can arise from a number of causes, such as disease, physical injury, poisoning, or malnutrition. These agents may affect either afferent or efferent nerves. Depending upon the cause of damage, the nerve cell axon, its protective myelin sheath, or both may be injured or destroyed.
CLASSIFICATION. There are hundreds of polyneuropathies. Reflecting the scope of PNS activity, symptoms may involve sensory, motor, or autonomic functions. To aid in diagnosis and treatment, symptoms are classified into principal neuropathic syndromes, based on the type of affected nerves and how long symptoms have been developing. Acute development refers to symptoms that have appeared within days, and subacute refers to those that have evolved over a number of weeks. Early chronic symptoms are those that take from months to a few years to develop, and late chronic symptoms are those that have been present for several years.
The classification system is composed of six principal neuropathic syndromes, which are subdivided into more specific categories. By narrowing the possible diagnoses in this way, specific medical tests can be used more efficiently and effectively. The six syndromes and a few associated causes are:
- Acute motor paralysis accompanied by variable problems with sensory and autonomic functions: Neuropathies associated with this syndrome are mainly accompanied by motor nerve problems, but the sensory and autonomic nerves may also be involved. Associated disorders include Guillain-Barré syndrome, diphtheritic polyneuropathy, and porphyritic neuropathy.
- Subacute sensorimotor paralysis: The term sensorimotor refers to neuropathies that are mainly characterized by sensory symptoms but also have a minor component of motor nerve problems. Poisoning with heavy metals (e.g., lead, mercury, and arsenic), chemicals, or drugs are linked to this syndrome. Diabetes, Lyme disease, and malnutrition are also possible causes.
- Chronic sensorimotor paralysis: Physical symptoms may resemble those in the above syndrome but the time frame for symptom development is prolonged. This syndrome encompasses neuropathies arising from cancers, diabetes, leprosy, inherited neurologic and metabolic disorders, and hypothyroidism.
- Neuropathy associated with mitochondrial diseases: Mitochondria are organelles (structures within cells) responsible for handling a cell's energy requirements. When mitochondria are damaged or destroyed, the cell's energy requirements are not met and it can die.
- Recurrent or relapsing polyneuropathy: This syndrome covers neuropathies that affect several nerves and may come and go, such as Guillain-Barré syndrome, porphyria, and chronic inflammatory demyelinating polyneuropathy.
- Mononeuropathy or plexopathy: Nerve damage associated with this syndrome is limited to a single nerve or a few closely associated nerves. Neuropathies related to physical injury to the nerve, such as carpal tunnel syndrome and sciatica, are included in this syndrome.
Causes and symptoms
Typical symptoms of neuropathy relate to the type of affected nerve. If a sensory nerve is damaged, common symptoms include numbness, tingling in the area, a prickling sensation, or pain. Pain associated with neuropathy can be quite intense and may be described as cutting,
Symptoms may appear over days, weeks, months, or years. Their duration and the ultimate outcome of the neuropathy are linked to the cause of the nerve damage. Potential causes include diseases, physical injuries, poisoning, and malnutrition or alcohol abuse. In some cases neuropathy is not the primary disorder but a symptom of an underlying disease.
Diseases that cause polyneuropathies may be acquired or inherited; in some cases it is difficult to make the distinction. The diabetes-polyneuropathy link has been well established. A typical pattern of diabetes-associated neuropathic symptoms includes sensory effects that first begin in the feet. The associated pain or pinsand-needles, burning, crawling, or prickling sensations, form a typical "stocking" distribution in the feet and lower legs. Other diabetic neuropathies affect the autonomic nerves and have potentially fatal cardiovascular complications.
Several other metabolic diseases have a strong association with polyneuropathy. Uremia (chronic kidney failure) carries a 10%-90% risk of eventually developing neuropathy, and there may be an association between liver failure and polyneuropathy. Atherosclerosis (accumulation of lipids inside blood vessels) can impair blood supply to certain peripheral nerves. Without oxygen and nutrients the nerves slowly die. Mild polyneuropathy may develop in patients with hypothyroidism (low thyroid hormone levels). Individuals with acromegaly (abnormally enlarged skeletal extremities caused by an excess of growth hormone) may also develop mild polyneuropathy.
Neuropathy can also result from vasculitis, a group of disorders in which blood vessels are inflamed. When the blood vessels are inflamed or damaged, blood supply to the nerve can be affected, injuring the nerve.
Both viral and bacterial infections have been implicated in polyneuropathy. Leprosy is caused by the bacterium M. leprae, which directly attacks sensory nerves. Other bacterial illnesses may set the stage for an immune-mediated attack on the nerves. For example, one theory about Guillain-Barré syndrome involves complications following infection with Campylobacter jejuni, a bacterium commonly associated with food poisoning. This bacterium carries a protein that closely resembles components of myelin. The immune system launches an attack against the bacteria; but, according to the theory, the immune system confuses the myelin with the bacteria in some cases and attacks the myelin sheath as well. The underlying cause of neuropathy associated with Lyme disease is unknown; the bacteria may either precipitate an immune-mediated attack on the nerve or inflict damage directly.
Infection with certain viruses is associated with extremely painful sensory neuropathies. Shingles is an example of such a neuropathy. After a case of chickenpox the causative virus, varicella-zoster virus, becomes inactive or latent in sensory nerves. Years later the virus may be reactivated and, once reactivated, attacks and destroys axons. Infection with HIV is also associated with polyneuropathy, but the type of neuropathy that develops can vary. Some HIV-linked neuropathies are noted for myelin destruction rather than axonal degradation. Also, HIV infection is frequently accompanied by other infections, both bacterial and viral, that are associated with neuropathy.
Several types of polyneuropathies are associated with inherited disorders. These inherited disorders may primarily involve the nervous system, or the effects on the nervous system may be secondary to an inherited metabolic disorder. Inherited neuropathies fall into several of the principal syndromes because symptoms may be sensory, motor, or autonomic. The inheritance patterns also vary depending upon the specific disorder. The development of inherited disorders is typically prolonged over several years and may herald a degenerative condition—that is, a condition that becomes progressively worse over time. Even among specific disorders there may be a degree of variability in inheritance patterns and symptoms. For example, Charcot-Marie-Tooth disease is usually inherited as an autosomal dominant disorder; however, it can be autosomal recessive or, in rare cases, linked to the X chromosome. Its estimated frequency is approximately one in 2,500 people. Age of onset and sensory nerve involvement can vary between cases. The main symptom is a degeneration of the motor nerves in legs and arms with resultant muscle atrophy. Other inherited neuropathies have a distinctly metabolic component. For example, in familial amyloid polyneuropathies, protein
Accidental injuries during sports and recreational activities are common causes of polyneuropathy. The common types of injuries in these situations occur from placing too much pressure on the nerve, exceeding the nerve's capacity to stretch, blocking adequate blood supply of oxygen and nutrients to the nerve, and tearing the nerve. Pain may not always be immediately noticeable, and obvious signs of damage may take a while to develop.
These injuries usually affect one nerve or a group of closely associated nerves. For example, a common injury encountered in contact sports such as football is the "burner," or "stinger," syndrome. Typically, a stinger is caused by overstretching the main nerves that span from the neck into the arm. Immediate symptoms are numbness, tingling, and pain that travels down the arm, lasting only a minute or two. A single incident of a stinger is not dangerous, but recurrences can eventually cause permanent motor and sensory loss.
The poisons, or toxins, that cause polyneuropathy include drugs, industrial chemicals, and environmental toxins. Neuropathy that is caused by drugs usually involves sensory nerves on both sides of the body, particularly in the hands and feet; and pain is a common symptom. Neuropathy is a rare side effect of prescription medications. A few drugs that have been linked with polyneuropathy include metronidazole, an antibiotic; phenytoin, an anticonvulsant; and simvastatin, a cholesterol-lowering medication.
Certain industrial chemicals are neurotoxic (poisonous to nerves) following work-related exposures. Such chemicals as acrylamide, allyl chloride, and carbon disulfide have been strongly linked to development of polyneuropathy. Organic compounds, such as N-hexane and toluene, are also encountered in work-related settings, as well as in glue-sniffing and solvent abuse. Either route of exposure can produce severe sensorimotor neuropathy that develops rapidly.
Heavy metals are the third group of toxins that cause polyneuropathy. Lead, arsenic, thallium, and mercury usually are not toxic in their elemental form, but rather as components in organic or inorganic compounds. The types of metal-induced neuropathies vary widely. Arsenic poisoning may mimic Guillain-Barré syndrome; lead affects motor nerves more than sensory nerves; thallium produces painful sensorimotor neuropathy; and the effects of mercury are seen in both the CNS and PNS.
Malnutrition and alcohol abuse
Burning, stabbing pains and numbness in the feet, and sometimes in the hands, are distinguishing features of alcoholic neuropathy. The level of alcohol consumption associated with this variety of polyneuropathy has been estimated as approximately 3 liters of beer or 300 milliliters of liquor daily for three years. However, it is unclear whether alcohol alone is responsible for the neuropathic symptoms, because chronic alcoholism is strongly associated with malnutrition.
Malnutrition refers to an extreme lack of nutrients in the diet. It is unknown precisely which nutrient deficiencies cause polyneuropathies in alcoholics and famine and starvation victims, but it is suspected that the B vitamins have a significant role. For example, thiamine (vitamin B1) deficiency is the cause of beriberi, a neuropathic disease characterized by heart failure and painful polyneuropathy of sensory nerves. Vitamin E deficiency seems to have a role in both CNS and PNS neuropathy.
Clinical symptoms can indicate polyneuropathy, but an exact diagnosis requires a combination of medical history, medical tests, and possibly a process of exclusion. Certain symptoms may suggest a diagnosis, but more information is commonly needed. For example, painful, burning feet may be a symptom of alcohol abuse, diabetes, HIV infection, or an underlying malignant tumor, among other causes. Without further details effective treatment would be difficult.
During the history and physical examination, the physician obtains detailed information about the location, nature, and duration of symptoms to exclude some causes or even pinpoint the actual problem. The patient's medical history may also provide clues as to the cause, because certain diseases and medications are linked to specific polyneuropathies. A medical history should also include information about diseases that run in the family, because some polyneuropathies are genetically linked. Information about hobbies, recreational activities, alcohol consumption, and workplace activities can uncover possible injuries or exposures to poisonous substances.
The evaluation of a patient with polyneuropathy also includes laboratory tests, such as blood levels of glucose and creatinine, to detect diabetes and kidney problems, respectively. A complete blood count (CBC) is also done to determine levels of different blood cell types. Iron, vitamin B12, folic acid, and other factors may be measured to rule out malnutrition. More specific tests, such as an assay for heavy metals or poisonous substances, or tests to detect vasculitis, are not typically performed
unless there is reason to suspect a particular cause. Routine and specialized blood tests are generally performed by a laboratory technologist.
An individual with neuropathy may be referred to a neurologist (physician specializing in nervous system disorders). By considering the results of the physical examination and observing information supplied by the referring primary care physician, the neurologist may be able to narrow down the possible diagnoses. Additional tests, such as nerve conduction studies and electromyography, which tests muscle reactions, can confirm that nerve damage has occurred and may also be able to indicate the nature of the damage. For example, if the neuropathy is caused by destruction of the myelin, damage is shown by slowed nerve conduction. If the axon itself has suffered damage, the nerve conduction may be slowed but will also be diminished in strength. Electromyography (performed by technologists often known as electromyographers or EMG technicians) adds further information by measuring nerve conduction and muscle response, which determine whether the symptoms are due to a neuropathy or a muscle disorder.
In approximately 10% of polyneuropathy cases a nerve biopsy may be helpful. In this test the physician surgically removes a small part of the nerve for examination under a microscope. This procedure is usually performed to confirm a suspected diagnosis rather than as an initial diagnostic procedure.
Treat the cause
Attacking the underlying cause of the neuropathy can prevent further nerve damage and may allow for better recovery. For example, in cases of such bacterial infections as leprosy or Lyme disease, antibiotics may be given to destroy the infectious bacteria. Viral infections are more difficult to treat because antibiotics are not effective against them. Neuropathies associated with drugs, chemicals, and toxins are treated in part by stopping
In a crisis situation, as in the onset of Guillain-Barré syndrome, plasma exchange, intravenous immunoglobulin, and steroids may be prescribed. Intubation and mechanical ventilation may be required to support the respiratory system. Treatment may focus more on symptom management than on combating the underlying cause, at least until a definitive diagnosis has been made.
Supportive care and long-term therapy
Some polyneuropathies cannot be resolved; or may require considerable time for resolution. In these cases long-term monitoring and supportive care are necessary. Medical tests may be repeated to chart the progress of the neuropathy. If autonomic nerve involvement is a concern, regular monitoring of the cardiovascular system may be performed.
Because pain is associated with many neuropathies, pain management is an important aspect of treatment, especially if the pain becomes chronic. As in any chronic disease, narcotics are best avoided. Agents that may relieve neuropathic pain include amitriptyline, carbamazepine, and capsaicin cream. Physical therapy and physician-directed exercises can help maintain or improve function. When motor nerves are affected, braces and other supportive equipment can aid patients' ability to move about.
The outcome for polyneuropathy depends heavily upon the underlying cause. Polyneuropathy ranges from a reversible problem to a potentially fatal complication. In the best cases a damaged nerve regenerates. Though nerve cells cannot be replaced if they are killed, they are capable of recovering from damage. The extent of recovery depends upon the extent of the damage and the patient's age and general health status. Recovery can take weeks to years because neurons grow very slowly. Full recovery may not be possible, and it may not be possible to determine the prognosis at the outset.
If the neuropathy is a degenerative condition, such as Charcot-Marie-Tooth disease, then the patient's condition will worsen although there may be periods when the disease seems to plateau. Cures have not yet been discovered for many degenerative diseases. For patients with incurable neuropathies, continued symptoms with a potential to worsening to disabilities, are to be expected.
A few polyneuropathies are eventually fatal. Fatalities from polyneuropathies have been associated with some cases of diphtheria, botulism, and other causes. Some diseases associated with neuropathy may also be fatal, but the ultimate cause of death is not necessarily related to the neuropathy—such as with cancer.
Health care team roles
The composition of the health care team treating patients with polyneuropathies will necessarily vary depending upon the underlying cause of the condition. For example, patients suffering from diabetes may be managed by physicians specializing in internal medicine and/or endocrinology. Cancer patients are often managed by oncologists, and patients with degenerative neurological disorders are treated by neurologists. Nearly all patients will also be cared for by laboratory technologists, radiological technologists, and nurses—the latter providing education about the disorder and management of the patient at home, and home safety assessments.
Patients requiring rehabilitation services may be seen by physiatrists (physician specialists in physical medicine), as well as physical and occupational therapists. Patients with diabetes and other metabolic or endocrine disorders also may receive counseling from registered dieticians and nutritionists to assist them to better manage these chronic diseases.
Polyneuropathies are preventable only to the extent that the underlying causes are preventable. Primary prevention includes vaccines against diseases that cause neuropathy, such as polio and diphtheria. Timely treatment for physical injuries may help prevent permanent or worsening damage to nerves. Precautions when using certain chemicals and drugs are well advised in order to prevent exposure to neurotoxic agents. Control of such chronic diseases as diabetes may also reduce the risk of developing polyneuropathy.
Although not a preventive measure, genetic screening can serve as an early warning for potential problems. Genetic screening is available for some inherited conditions, but not all. In some cases presence of a particular gene does not necessarily mean the person will develop the disease because environmental and other components may be involved.
Afferent—Refers to peripheral nerves that transmit signals to the spinal cord and the brain. These nerves carry out sensory function.
Autonomic—Refers to peripheral nerves that carry signals from the brain and control such involuntary actions in the body as the beating of the heart.
Autosomal dominant or autosomal recessive—Refers to the inheritance pattern of a gene on a chromosome other than X or Y. Genes are inherited in pairs—one gene from each parent. However, the inheritance may not be equal, and one gene may overshadow the other in determining the final form of the encoded characteristic. The gene that over-shadows the other is called the dominant gene; the overshadowed gene is the recessive one.
Axon—A long, threadlike projection that is part of a nerve cell.
Central nervous system (CNS)—The part of the nervous system that includes the brain and the spinal cord.
Efferent—Refers to peripheral nerves that carry signals away from the brain and spinal cord. These nerves carry out motor and autonomic functions.
Electromyography—A medical test that assesses nerve signals and muscle reactions. It can determine if there is a disorder with the nerve or if the muscle is not capable of responding.
Inheritance pattern—Refers to dominant or recessive inheritance.
Motor—Refers to peripheral nerves that control such voluntary movements as moving the arms and legs.
Myelin—The protective coating on axons.
Nerve biopsy—A medical test in which a small portion of a damaged nerve is surgically removed and examined under a microscope.
Nerve conduction—The speed and strength of a signal being transmitted by nerve cells. Testing these factors can reveal the nature of nerve injury, such as damage to nerve cells or to the protective myelin sheath.
Neurotransmitter—Chemicals within the nervous system that transmit information from or between nerve cells.
Peripheral nervous system (PNS)—Nerves that are outside of the brain and spinal cord.
Sensory—Refers to peripheral nerves that transmit information from the senses to the brain.
Adams, Raymond D., Maurice Victor, and Allan H. Ropper. "Diseases of the Peripheral Nerves." In Principles of Neurology, 6th ed. New York: McGraw-Hill, 1997.
Humes, H. David, ed. Kelley's Textbook of Internal Medicine. Philadelphia: Lippincott Williams & Wilkins, 2000, 2764-2765.
American Diabetes Association. 1660 Duke St., Alexandria, VA 22314. (800) DIABETES. <http://www.diabetes.org>.
Charcot-Marie-Tooth Association. Crozer Mills Enterprise Center. 601 Upland Ave., Upland, PA 19015. (800) 606-2682. <http://www.charcot-marie-tooth.org>.
Guillain-Barré Syndrome Foundation International. P.O. Box 262, Wynnewood, PA 19096. (610) 667-0131. <http://www.webmast.com/gbs>.
The Myelin Project. 1747 Pennsylvania Ave., NW, Ste. 950, Washington, DC 20006. (202) 452-8994. <http://www.myelin.org>.
The Neuropathy Association. 60 E. 42nd St., Suite 942, New York, NY 10165. (800) 247-6968. <http://www.neuropathy.org/association.html>.
Table Of Contents
- Nerve cells and nerves
- Peripheral nervous system
- Causes and symptoms
- Physical injury
- Malnutrition and alcohol abuse
- Treat the cause
- Supportive care and long-term therapy
- Health care team roles
- KEY TERMS